Navigation Links
Amylin Pharmaceuticals to Webcast Third Quarter Results
Date:10/15/2008

SAN DIEGO, Oct. 15 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will Webcast its Quarterly Update Conference Call for the third quarter of 2008 on Tuesday, October 21, 2008 at 5:00 p.m. ET/2:00 p.m. PT. Daniel M. Bradbury, Amylin's President and Chief Executive Officer, will lead the call. On the same date post-market, Amylin will release financial results for the third quarter of 2008.

The call will be Webcast live through Amylin's corporate Web site and a recording will be made available following the close of the call. To access the Webcast, please log on to http://www.amylin.com approximately fifteen minutes prior to the call to register, download and install any necessary audio software. For those without access to the Internet, the live call may be accessed by phone by calling (888) 536-6007 (U.S./Canada) or (706) 758-4632 (international), Conference ID# 68128288. A replay of the call will also be available by phone beginning approximately two hours after the close of the call and can be accessed at (800) 642-1687 (U.S./Canada) or (706) 645-9291 (international), Conference ID# 68128288.

About Amylin Pharmaceuticals, Inc.

Amylin Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide) injection. Amylin's research and development activities leverage the company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is located in San Diego, Cal
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Amylin Pharmaceuticals to Present at Thomas Weisel Healthcare, BioCentury NewsMakers, and Morgan Stanley Global Healthcare Conferences
2. Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA
3. Amylin and Lilly Set Date and Time for Conference Call
4. Amylin Pharmaceuticals to Webcast Second Quarter Results
5. Amylin Pharmaceuticals to Present at Goldman Sachs Global Healthcare Conference
6. Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008
7. Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders
8. Amylin Pharmaceuticals to Present at FBR Capital Markets Investor Conference
9. Amylin Pharmaceuticals to Present at Baird Growth Stock Conference
10. Amylin Pharmaceuticals to Present at Bank of America Healthcare Conference
11. Amylin Pharmaceuticals Announces Time Change to Previously Announced Presentation at the Morgan Stanley Global Healthcare Unplugged Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., British Columbia, Dec. 1 /PRNewswire-FirstCall/ ... of The Dow Chemical Company (NYSE: DOW ), and A...ing of a research and commercial license option ag...ith access to Agrisoma,s proprietary Engineered Tr... major food crops, and on a non-exclusive basis, i...
(Date:12/1/2009)...ing provider of products for biological sample col...l Services will offer Oragene•DNA sample coll... and genotyping service. , ...tek , a leading provider of products for biologica...Pharmaceutical Services will offer Oragene•...
(Date:12/1/2009)... 34-year veteran of the high-technology industry, ...s development and intellectual property management...ace. The company also plans to invest in promisin...or. , Monterey, CA (PRWEB...r veteran of the high-technology industry, has for...
(Date:11/30/2009)...Newswire/ -- The Michael J. Fox Foundation for Par...ion in total awards to six research teams working ... for Parkinson,s disease. The funding was awarded ...Parkinson,s Disease program, made possible by fun...neuroscience-based biotechnology company. ,, T...
Breaking Biology Technology:Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 3Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 2Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 3Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 2Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 3Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 4The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3
...DW Corp. , the Illinois-based technology provider ...s , is elevating a top salesman to handle Berbee,s...put vice president of sales Steven Schuldt in char...olutions provider, into CDW. , ,CDW, headquartered...d Berbee on Oct. 11 for approximately $184 million...
... is the second in a series of articles on developi...nology realm. The first edition of Early Stage f..., , Madison, Wis. - So now that you know you ha...nology, either one of which could be branded, what... will discuss how you pick your business name. In ...
... There are signs the United States economy is cool...ting in the third quarter is not one of them, acco...capitalists invested $6.2 billion in 797 deals dur...decline in both categories, according to a MoneyT...ational Venture Capital Association based on data...
Other Biology Technology:Early Stage Step 2: Choosing a domain name 2Early Stage Step 2: Choosing a domain name 3Early Stage Step 2: Choosing a domain name 4Venture capital above $6B for third straight quarter 2Venture capital above $6B for third straight quarter 3
(Date:12/1/2009)...Particularly in Alzheimer,s disease, nerve cell de...w therapeutic options may possibly be derived from...m. These findings have been published in the curre...nce . Until only a few years ago, neurogenesis th...d to be impossible in the adult brain. The textboo...
(Date:12/1/2009)...Yehezkel Ben-Ari, winner of the 2009 Inserm Grand ...d its commitment to paying tribute to outstanding,...s. By honouring talents, Inserm intends to,demons...ved in today,s biological, medical and,health res...nd women who carry out and,drive this research ea...
(Date:12/1/2009)...In a world first, a Monash University-led internat...y to boost the output of the next generation of so... collaboration with colleagues from the universiti... tandem dye-sensitised solar cells with a three-fo...ed with previously reported tandem dye-sensitised ...
Breaking Biology News(10 mins):New source discovered for the generation of nerve cells in the brain 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 3Innovation puts next-generation solar cells on the horizon 2Cardium Announces Plans to File FDA 510 28k 29 Application for U S Marketing Clearance of ExcellagenXL 28TM 29 Gel for Diabetic Pressure and Venous 14682 1Cardium Announces Plans to File FDA 510 28k 29 Application for U S Marketing Clearance of ExcellagenXL 28TM 29 Gel for Diabetic Pressure and Venous 14682 2Cardium Announces Plans to File FDA 510 28k 29 Application for U S Marketing Clearance of ExcellagenXL 28TM 29 Gel for Diabetic Pressure and Venous 14682 3Cardium Announces Plans to File FDA 510 28k 29 Application for U S Marketing Clearance of ExcellagenXL 28TM 29 Gel for Diabetic Pressure and Venous 14682 4China National Medicines Corporation Issues Milestone Purchase Order for 12 000 STA Systems 5913 1China National Medicines Corporation Issues Milestone Purchase Order for 12 000 STA Systems 5913 2China National Medicines Corporation Issues Milestone Purchase Order for 12 000 STA Systems 5913 3China National Medicines Corporation Issues Milestone Purchase Order for 12 000 STA Systems 5913 4Global Atrial Fibrillation Device Market to Grow by Almost 10 25 Through 2013 5910 1Global Atrial Fibrillation Device Market to Grow by Almost 10 25 Through 2013 5910 2Global Atrial Fibrillation Device Market to Grow by Almost 10 25 Through 2013 5910 3
...at help shape our understanding of how tool use ha...red evidence that chimpanzees, at least under some...and using tools to hunt mammalian prey. The work, ...nd Paco Bertolani of the University of Cambridge, ...on February 22nd. , Chimpanzees are well known for...
...ersion of a computer chip, a team led by Johns Hop...y related to the mating habits of yeast cells. ,...line Publication of the journal Nature, shed new l...m one another and from the environment through a p...hen impaired, can lead to cancer or other illnesse...
...tion and large scale culture of stem cells for pot...n cell biology. In an upcoming PLoS ONE paper, res...y, France) report, on the basis of experimental ob... cell identity in culture may strongly depend on t...s are in line with the currently emerging view tha...
Other Biology News:Chimpanzees found to use tools to hunt mammalian prey 2Microfluidic chip helps solve cellular mating puzzle 2Microfluidic chip helps solve cellular mating puzzle 3
Wheat Germ Agglutinin (WGA) PS SPA Imaging Bead from GE Healthcare, formerly Amersham Biosciences
...s to 1 outflow Single-cell and patch delivery Re...illisecond) solution change Very small dead volum...Solid construction 360, 250 and 100 micron delive...manipulator Available in 4, 8, and 16 channels. S...
Sf21 Frozen Cells (Grace's Media) from Invitrogen
... most comprehensive, cost-effective solution to yo...orated unprecedented quality into both our product...etection chemistries and antibodies that have been...des our competitively priced accessories that can ...
Biology Products: